phrykt

Biofrontera Inc. (BFRI): who owns it and who trades it

As of Nov 13, 2026, no open-market insider purchases or sales of BFRI were reported in the last 12 months. 1 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 13, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Insider trades

No BFRI insider reported an open-market purchase or sale in the last 12 months.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$0
0 trades, 0 people
Sales under a 10b5-1 plan
–
Share of sale value
Latest trade
–
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

BFRI short interest

Low short interest. 1.3% of BFRI shares are sold short: about 1 share in 78. Over the last 12 reports the number of shares short went up 125%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 189,627 BFRI shares were sold short, 1.3% of the shares outstanding, up 83.8% from the report before. At the average daily volume of 146,358 shares, buying them all back would take about 1.3 trading days (days to cover).

Shares short, % of all shares

1.28%May 15Oct 303.57%

Days to cover

1.3May 15Oct 301.3

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 2026189,6271.28%+84%146,3581.3
Oct 15, 2026103,1480.69%-30%324,2341.0
Sep 30, 2026146,8510.99%-68%403,0961.0
Sep 15, 2026464,8253.13%+82%1.04M1.0
Aug 31, 2026255,2721.72%+676%674,9001.0
Aug 14, 202632,9070.22%-46%464,2831.0
Jul 31, 202661,0790.52%+153%359,8261.0
Jul 15, 202624,1570.21%-13%437,6401.0
Jun 30, 202627,8900.24%-50%314,1761.0
Jun 15, 202656,0550.48%-19%203,2351.0
May 29, 202669,3360.60%-18%130,6481.0
May 15, 202684,3960.72%+11%354,7591.0

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Biofrontera company events

Biofrontera filed 10 reports on Form 8-K in the last 12 months, 1 of them about an important change (listing). The latest was on Sep 14, 2026.

  1. Sep 14, 2026AnnouncementBiofrontera Inc. issued a press release announcing that it has received notification from the U.S. Food and Drug Administration that the FDA had approved the Company’s supplemental New Drug Application for Ameluz ® (aminolevulinic acid hydrochloride) topical gel, 10%, in combination with… Filing
  2. Aug 13, 2026ResultsReleased financial results. Filing
  3. Jun 17, 2026VoteReported shareholder vote results. Filing
  4. May 14, 2026ResultsReleased financial results. Filing
  5. Mar 19, 2026ResultsReleased financial results. Filing
  6. Mar 9, 2026AnnouncementShared information with investors. Filing
  7. Feb 26, 2026AnnouncementAs previously disclosed in reports filed by Biofrontera Inc. with the Securities and Exchange Commission, in June 2024, Sun Pharmaceutical Industries, Inc. instituted proceedings against the Company and certain of its affiliates in the U.S. District Court for the District of Massachusetts and the… Filing
  8. Feb 9, 2026AnnouncementShared information with investors. Filing
  9. Jan 13, 2026ResultsReleased financial results. Filing
  10. Jan 7, 2026ListingBiofrontera Inc., a Delaware corporation, received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC notifying the Company that the listing of its common stock was not in compliance with Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital… Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Biofrontera financials

Famous investors that hold BFRI

1 of the 50 well-known investors we track reported holding BFRI in their latest 13F filing. The largest position is Jim Simons's, worth $714K.

FundQuarterSharesValueOf portfolioChange
Jim Simons · Renaissance TechnologiesQ3 2026660,781$714K0.0%+320%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named BFRI in the last 120 days.

FiledHolderFormStake
Nov 13, 2026Rosalind Advisors, Inc.13G/A9.9%
Nov 13, 2026Rosalind Advisors, Inc.13G/A9.9%

Questions about Biofrontera Inc. (BFRI) stock

Are BFRI insiders buying or selling?

No BFRI insider reported an open-market purchase or sale on Form 4 in the last 12 months. Share awards, option exercises and gifts are not counted.

What is the short interest in BFRI?

As of Oct 30, 2026, 189,627 BFRI shares were sold short, 1.3% of the shares outstanding, up 83.8% from the report before. At the average daily volume of 146,358 shares, buying them all back would take about 1.3 trading days (days to cover). See the history.

Which famous investors hold BFRI?

1 of the 50 well-known investors we track reported BFRI in their latest 13F filing, including Jim Simons. The largest position is worth $714K. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.